Various cytokines produced by bone marrow cells can protect adult cardiomyocytes against apoptosis. Thus, we investigated the feasibility of implanting adult cardiomyocytes in combination with bone marrow cells for myocardial repair. Ventricular cardiomyocytes were isolated from adult rats and cocultured with bone marrow cells. Using a rat model of doxorubicin-induced cardiomyopathy, we injected 6 × 10 5 adult cardiomyocytes, 3 × 10 7 bone marrow cells, or both into damaged hearts, for myocardial repair. Coculture of the cardiomyocytes with the bone marrow cells enhanced the expression of integrin-β1D and focal adhesion kinase in cardiomyocytes, resulting in increased survival and decreased apoptosis of the cardiomyocytes after 7 days of culture. Compared with the baseline levels, cardiac function was preserved by the implantation of bone marrow cells alone and by the implantation of cardiomyocytes in combination with bone marrow cells, but it was decreased significantly 28 days after the implantation of cardiomyocytes alone. Furthermore, apoptosis of the host cardiomyocytes was decreased significantly after the implantation of bone marrow cells alone, or in combination with cardiomyocytes, compared with that after the implantation of cardiomyocytes alone (p < 0.01). Interestingly, the implantation of adult cardiomyocytes in combination with bone marrow cells resulted in a dramatic increase in the survival of donor cardiomyocytes, and induced the myogenic differentiation of donor bone marrow stem cells. Our findings indicate that cardiomyocytes and bone marrow cells can assist and compliment each other; thus, the implantation of adult cardiomyocytes in combination with bone marrow cells shows promise as a feasible new strategy for myocardial repair.
INTRODUCTION
repair have been conducted worldwide by implanting autologous skeletal myoblasts and bone marrow-or bloodderived stem cells (3, 5, 17, 27) . Despite the safety and Cardiac transplantation is the last choice of effective treatment for patients with end-stage heart failure, but it feasibility reported in these clinical trials, the problems of poor myogenic differentiation by the implantation of is limited by the shortage of donor supply. Thus, alternative therapeutic options, especially using cell-based ap-bone marrow-or blood-derived stem cells and the potential risk of inducing ventricular arrhythmias by the im-proaches, have been developed recently to repair the failed heart (1, 3, 5, 11, 13, 14, 17, 18, 20, 27) . Various cell plantation of skeletal myoblasts have yet to be resolved (4, 16) . sources, including neonatal cardiomyocytes (18), adult cardiomyocytes (20), cardiac stem cells (1), myoblasts Adult cardiomyocytes have also been considered as cell sources for myocardial repair. However, the implan-(3), smooth muscle cells (13) , bone marrow-derived stem cells (5, 14, 17, 27) , and embryonic stem cell-derived tation of adult cardiomyocytes has not been trialed clinically because the collection of cardiomyocytes by biopsy cardiomyocytes (11) , have all shown considerable myogenic and angiogenic potency in different experimental is so invasive, the ex vivo expansion of adult cardiomyocytes is extremely difficult, and the survival of adult models of heart injury. Considering the immunological and ethical problems, autologous cells are still the most cardiomyocytes is very poor after implantation. However, for patients with dilated cardiomyopathy undergo-ideal and feasible cell sources for clinical application. In fact, a number of clinical trials of cell-based myocardial ing partial left ventriculectomy as treatment (22, 24) , we 696 LI ET AL.
can collect autologous adult cardiomyocytes from the plemented with 10% fetal calf serum and 1% penicillin/ streptomycin. Adult cardiomyocytes, bone marrow cells, excised ventricular myocardium and reuse these viable cardiomyocytes for implantation. In this situation, the or their mixture were plated on laminin (25 µg/ml)coated culture slides, and incubated in 5% CO 2 and 95% major problem of cardiomyocyte implantation is poor survival of the donor cardiomyocytes. As we have found air at 37°C. recently that cytokines produced by bone marrow cells TUNEL Assay and Immunochemistry Analysis can protect cardiomyocytes against apoptosis (25) , we tested herein the hypothesis that implanting adult cardio-
The survival of cardiomyocytes was counted under microscopy 1, 3, and 7 days after culture. To determine myocytes in combination with bone marrow cells will promote myocardial repair. In this combination, the if bone marrow cells protected the cardiomyocytes against apoptosis, the apoptotic cardiomyocytes were detected bone marrow cells will assist the survival of the implanted adult cardiomyocytes, and the cardiomyocytes by the terminal dUTP nick end-labeling (TUNEL) assay using Apoptosis Detection Kits (R&D System Inc. Min-will induce the myogenic differentiation of the bone marrow stem cells. neapolis, MN) after 7 days of cultivation. The apoptosis index was calculated as the number of apoptotic cardio-MATERIALS AND METHODS myocytes per 100 nucleated cardiomyocytes.
Animals
To investigate the mechanisms, the expressions of focal adhesion kinase (FAK) and myocyte-specific adhe-We obtained inbred male Wister rats from Japan SLC sion molecular of integrin-β1D in cardiomyocytes were Inc. (Hamamatsu, Japan), and hemizygous GFP-transdetected by immunostaining with rabbit anti-human FAK genic Wister rats from Health Science Research Repolyclonal antibody (Upstate Biotechnology, Inc. Lake sources Bank, Japan (8) . We used 12-to 14-week-old Placid, NY, USA) and mouse anti-integrin-β1D monorats weighing 250-300 g in this study. The rats were clonal antibody (Chemicon International, Temecula, housed under clean conditions, and all experiments were CA, USA), respectively. Cardiomyocytes were recogapproved by the institutional Animal Care and Use nized by immunostaining with mouse anti-myosin (ven-Committee of Yamaguchi University School of Meditricular heavy chain-β) monoclonal antibody (Chemicon cine.
Inc). Appropriate FITC-or R-PE-conjugated secondary Separation and Collection of Adult Cardiomyocytes antibodies were used to visualize positive staining. Slides and Bone Marrow Cells were also stained with 4′,6-diamidino-2-phenylindole (DAPI) to visualize nuclei. Positive labeled cells were Adult cardiomyocytes were isolated from 13-weekthen viewed under a fluorescence microscope. old rats, as described previously (25) . Briefly, the hearts were excised quickly and cannulated via the ascending Rat Cardiomyopathy Model and Cell Implantation aorta. The hearts were perfused for 2 min with Ca 2+ -free Doxorubicin-induced cardiomyopathy was generated minimal essential medium (MEM; Sigma) containing 5 as previously described (23) . Briefly, 70 rats (12 weeks mM taurin, 3.8 mM creatine, and 10 mM 2,3-butanediold) were injected IP with 2.5 mg/kg doxorubicin hydroone monoxime, at 37°C. After 30-min digestion with 0.8 chloride (Sigma, St. Louis, MO, USA) twice weekly for mg/ml collagenase B (Roche Applied Science, Indianap-3 weeks, to a total cumulative dosage of 15 mg/kg body olis, IN) in MEM containing 50 mM CaCl 2 , the left venweight. The rats were used for cell implantation 1 week tricle was removed and cut into several chunks. Cardioafter the complication of doxorubicin administration. myocytes were isolated by further digestion in the same Due to the toxicity of doxorubicin, 8 rats died before enzyme solution at 37°C in a shaker (60-70 rpm), and cell implantation, and 6 rats were not used for cell imcollected every 10 min. plantation because of severe body weight loss. The re-Bone marrow cells were collected as described premaining 56 rats randomly received cell implantation, as viously (25) . Briefly, bone marrow was collected from described previously (6) . Briefly, after left thoracotomy the femur and tibia of rats and suspended in phosphateunder general anesthesia, the rats received six injections buffered saline. Bone marrow mononuclear cells were intramyocardially using a 31-gauge needle and a 100-µl separated by gradient centrifugation. syringe, into the left ventricular wall: the CMC group,
Coculture of Adult Cardiomyocytes and Bone
given 1 × 10 5 /10 µl/injection to a total dose of 6 × 10 5 Marrow Cells adult cardiomyocytes; the BMC group, given a total dose of 3 × 10 7 bone marrow cells; and the CMC + For the coculture experiment, freshly isolated adult cardiomyocytes were suspended at a density of 5 × 10 4 BMC group, given injection with both 6 × 10 5 adult cardiomyocytes and 3 × 10 7 bone marrow cells. cells/ml, and freshly collected bone marrow cells were suspended at a density of 2 × 10 6 cells/ml, in MEM sup-We used 32 rats for the assessment of cardiac func-tion and myocyte apoptosis in CMC (n = 11), BMC Statistical Analysis (n = 11), and CMC + BMC (n = 10) groups, by implant-All data are expressed as the mean ± SD. Statistical ing cells collected from wild-type rats. However, to analysis was performed by one-way analysis of variance compare the survival of adult cardiomyocytes in the (ANOVA), followed by a Bonferroni t-test. A value of CMC and CMC + BMC groups, we collected donor p < 0.05 was considered significant. adult cardiomyocytes from GFP-transgenic rats, but RESULTS bone marrow cells from wild-type rats. These cells were implanted as described above (n = 6 in each group).
Increased Survival and Decreased Apoptosis of Conversely, to observe the survival and myogenic
Cardiomyocytes by Coculture With Bone Marrow Cells differentiation of bone marrow cells in the BMC and CMC + BMC groups, we collected adult cardiomyo-
The survival of cardiomyocytes was increased signifcytes from wild-type rats, but bone marrow cells from icantly after 3 and 7 days of coculture with bone marrow GFP-transgenic rats. These cells were also implanted as cells compared with that after 3 and 7 days of culture described above (n = 6 in each group). alone (11.96 ± 1.63 vs. 16.30 ± 2.03 at day 3, p < 0.05; and 6.08 ± 1.59 vs. 12.96 ± 1.75 at day 7, p < 0.01, re-Echocardiography spectively) ( Fig. 1A ). The number of TUNEL-positive cardiomyocytes was also decreased significantly by co-Cardiac function was measured before and 28 days culture with bone marrow cells after 7 days (3.42 ± after treatment, by a single observer blind to the treat-0.72% vs. 1.32 ± 0.33%, p < 0.01) ( Fig. 1B ). ment regimen, using echocardiography with a HDI-5000 ultrasound machine (Philips, Netherlands) equipped
Increased Expression of FAK and Integrin-β1D in with a 15-MHz probe (15) . After the induction of light Cardiomyocytes by Coculture With Bone Marrow Cells general anesthesia, the hearts were imaged two-dimen-
We observed that the cardiomyocytes shrank as the sionally in long-axis views at the level of the greatest time of culture extended, and that the majority of cardioleft ventricle (LV) diameter. We measured the systolic myocytes cultured alone became almost round after 7 and diastolic LV areas at the same time. This view was days of culture. However, the morphological change was used to position the M-mode cursor perpendicular to the milder in the cardiomyocytes cocultured with bone mar-LV anterior and posterior walls. The LV dimension was row cells (Fig. 2) . Furthermore, the expression of FAK measured at the end-diastole dimension (LVEDD) and and integrin-β1D was detected clearly after 7 days in at the end-systole dimension (LVESD). The percentage the cardiomyocytes cocultured with bone marrow cells, of LV fraction shortening (LVFS %) was calculated as:
whereas it was very dim or negative in the cardiomyo-
cytes cultured alone (Fig. 2) . These observations suggest that bone marrow cells increased the survival and inhib-Histological Evaluation ited the apoptosis of isolated cardiomyocytes, possibly After the echocardiography on day 28, the rats were through the enhancement of FAK and integrin-β1D exkilled with an overdose of anesthesia, and the hearts pression. were harvested. Samples were frozen in liquid nitrogen Cardiac Function After Cell Implantation and stored at −80°C until use. To observe the apoptosis of host cardiomyocytes, TUNEL assay was performed We assessed cardiac function by echocardiography before (baseline) and 28 days after cell implantation. All on 5-µm-thick frozen sections, as described above. Sections were also stained with DAPI to visualize nuclei.
of the rats had a low LVFS% at baseline, which indicated the cardiac damage induced by doxorubicin. Al-The apoptosis index was calculated as the number of TUNEL-positive myocyte nuclei per 1000 nuclei. At though we included initially 10-11 rats in each group for the assessment of cardiac function and cardiomyo-least 20 different fields were selected for random counting from three independent slides of each sample, and cytes apoptosis, 3 rats in the CMC group, 3 rats in the BMC group, and 1 rat in CMC + BMC group died the averages were used for statistical analysis.
The survival of the implanted adult cardiomyocytes within 2 weeks after cell implantation. Compared with the baseline, the LVFS% decreased further 28 days after and bone marrow cells was evaluated by direct visualization under fluorescence microscopy (15) . The myo-the implantation of adult cardiomyocytes alone (36.85 ± 4.02% vs. 30.27 ± 3.86%, p = 0.03) ( Fig. 3) . Conversely, genic differentiations of donor bone marrow cells were identified by immunostaining with mouse anti-myosin the LVFS% increased slightly after the implantation of bone marrow cells, alone (34.55 ± 3.71% vs. 36.74 ± (ventricular heavy chain-β) monoclonal antibody (Chemicon Inc.). Positively stained cells were detected after in-3.08%, p = 0.18) and in combination with adult cardiomyocytes (35.28 ± 3.53% vs. 38.57 ± 3.75%, p = 0.14), cubation with R-PE-conjugated secondary antibody. which resulted in a significantly higher LVFS% in the these rats 28 days after the implantation of cardiomyocytes in combination with bone marrow cells. However, BMC and CMC + BMC groups than in the CMC group, 28 days after treatment (p = 0.045 and 0.018 vs. the GFP-positive cardiomyocytes were rarely observed in the rats implanted with adult cardiomyocytes alone (Fig. CMC group, respectively) ( Fig. 3) . However, the LVFS% did not differ significantly between the BMC 5A). Quantitative analysis showed significantly more surviving donor cardiomyocytes in the CMC + BMC and CMC + BMC groups, 28 days after treatment (p = 0.33).
group than in the CMC group (0.317 ± 0.092/field vs. 0.015 ± 0.023/field) ( Fig. 5B ).
Apoptosis of Host Cardiomyocytes
Survival and Myogenic Differentiation of the Implanted TUNEL staining analysis revealed that the apop-Bone Marrow Cells totosis of host cardiomyocytes was significantly higher in the rats implanted with adult cardiomyocytes alone To observe the survival and differentiation of bone marrow cells, donor bone marrow cells were collected (22.07 ± 3.35/10 3 nuclei) than in those implanted with bone marrow cells alone (11.49 ± 2.59/10 3 nuclei, p < from GFP-transgenic rats, whereas cardiomyocytes were isolated from adult wild-type rats for implantation. Al-0.01) or cardiomyocytes in combination with bone marrow cells (10.88 ± 2.70/10 3 nuclei, p < 0.01) ( Fig. 4) .
though the survival of bone marrow cells did not differ obviously between the BMC and CMC + BMC groups However, the apoptotosis of host cardiomyocytes did not differ significantly between the BMC and CMC + (Fig. 6A) , the myosin-positive bone marrow cells were significantly higher in the rats implanted with bone mar-BMC groups.
row cells in combination with cardiomyocytes than in Survival of Implanted Donor Adult Cardiomyocytes the rats implanted with bone marrow cells alone (0.906 ± 0.170/field vs. 0.112 ± 0.110/field) ( Fig. 6B) . To observe the survival of donor adult cardiomyocytes after implantation, donor cardiomyocytes were iso-DISCUSSION lated from GFP-transgenic rats, but bone marrow cells were collected from wild-type rats. We observed that Many experimental studies and clinical trials have shown that the delivery of various cells into the injured some of the GFP-positive cardiomyocytes survived in heart can potentially improve myocardial perfusion and
Using an in vitro coculture model, we confirmed that bone marrow cells could increase survival and inhibit cardiac function (1, 3, 5, 11, 13, 14, 17, 18, 20, 27) . However, because of the specific electrophysiological, structural, apoptosis of isolated adult cardiomyocytes. We found that most of the cardiomyocytes shrank as the time of and contractile properties of the myocardium, regenerating new functional myocardium by cell implantation culture became longer and that most of those cultured alone became round within 7 days of culture; however, needs the differentiation and maturation of donor cells into true cardiomyocytes, followed by physiological these morphological changes were mild in the cardiomyocytes cocultured with bone marrow cells. As most ad-coupling with host cardiomyocytes. Although fetal or neonatal cardiomyocytes and ES-derived cardiomyo-herent cell types need to attach and spread to the extracellular matrix for their growth and survival (9, 19) , we cytes have the same electrophysiological and structural properties, immunological and ethical problems hinder investigated the expression of adhesion molecules in cardiomyocytes. We observed the expression of inte-the clinical application of allogenic implantation. Therefore, autologous bone marrow stem cells and skeletal grin-β1D distinctly in the cardiomycytes after 7 days of coculture with bone marrow cells, whereas it was de-myoblasts have been selected as temporary cell sources for myocardial repair (3, 5, 17, 27) . Although encouraging creased and seen very dimly in the cardiomycytes cultured alone. This absence of attachment was attributed results have been reported in preliminary clinical trials (3, 5, 17, 27) , including improvements in myocardial per-to the apoptosis of the cardiomyocytes. Furthermore, we found that FAK, an integrin-mediated signaling com-fusion and cardiac function, the regeneration of new functional myocardium cannot be expected from the im-plex, decreased in the cardiomycytes without coculture. Previous studies have reported the importance of myo-plantation of bone marrow stem cells or skeletal myoblasts directly, because of their lack of specific electro-cyte survival signals transmitted by FAK (7, 21) , and that attenuating FAK signaling can lead to apoptosis (10) . physiological and structural properties. Quantitative analysis showed a low LVFS% before cell implantation (baseline), and no significant difference among the three groups. However, 28 days after treatment, the LVFS% was significantly lower than the baseline in the CMC group, implanted with adult cardiomyocytes only (p = 0.03), whereas it was higher than the baseline in the BMC group, implanted with bone marrow cells, and in the CMC + BMC group, implanted with cardiomyocytes in combination with bone marrow cells (p = 0.045 and 0.018 vs. the CMC group, respectively). Thus, the increased survival of cardiomyocytes by co-the implantation of bone marrow cells alone. This is why we injected only 5 million adult cardiomyocytes culture may be related to the enhanced expression of integrins and their associated protein, FAK. Various per rat, and far fewer cardiomyocytes survived. We speculate that the small number of surviving donor growth factors, including VEGF, IGF-1, and angiopoietin, have been shown to induce the activation and sub-cardiomyocytes was not enough to influence the global cardiac function. cellular translocation of FAK in cardiomyocytes (2, 25, 26) . As various growth factors, including VEGF, IGF-1, It is well known that cardiomyocytes are sensitive to ischemic injury. As we used a nonischemic heart injury and angiopoietin, can be produced by bone marrow cells (12, 25) , we speculate that the growth factors released by model in this study, we must identify whether combined implantation with bone marrow cells in an ischemic bone marrow cells play an important role in protecting cardiomyocytes and enhancing their survival.
heart would increase the survival of donor cardiomyocytes. Previous reports have found that the cytokines Based on these in vitro data, we investigated the potency of intramyocardial implantation of adult cardio-produced by bone marrow cells can protect cardiomyocytes against ischemic-induced damage (12, 25) , and that myocytes in combination with bone marrow cells for myocardial repair in a drug-induced cardiomyopathy the implantation of bone marrow cells can improve regional blood flow by enhancing therapeutic angiogen-model in rats. We injected a total of 3 × 10 7 bone marrow cells into the damaged heart because similar dose esis (12, 25) . These findings support our speculation that this would be reproducible in an ischemic heart. How-of bone marrow cells was observed to be effective in our previous study (6) . Furthermore, approximately 20% ever, we did not investigate the formation of a gap junction between donor cells and host cardiomyocytes and of the left ventricular myocardium will be excised by surgical partial left ventriculectomy in patients with di-we do not know if the surviving donor cardomyocytes and myogenic differentiated myosin-positive bone mar-lated cardiomyopathy. Considering the feasibility for future clinical application, we only separated cardiomyo-row coupled physiologically with the host cardiomyocytes. Further study is required to identify the functional cytes from the left ventricle for implantation in this study. As we can separate and collect about 2-3 × 10 6 regeneration of new myocardium by the implantation of adult cardiomyocytes in combination with bone marrow adult cardiomyocytes from the left ventricular myocardium of one rat, we also used approximately 20% (6 × cells.
In conclusion, this coculture experiment showed that 10 6 ) of total collected cardiomyocytes of one rat for implantation. The numbers of bone marrow cells and cardi-bone marrow cells can increase the survival and inhibit the apoptosis of adult cardiomyocytes, which might be omyocytes used for implantation in this study was also the rational maximum numbers that we would be ex-related to the enhanced expression of FAK and integrins. Using a doxorubicin-induced cardiomyopathy model, pected to use for clinical patients.
Compared with the implantation of adult cardiomyo-we found that the implantation of adult cardiomyocytes in combination with bone marrow cells inhibited the ap-cytes alone, the implantation of adult cardiomyocytes in combination with bone marrow cells decreased the apo-optosis of host cardiomyocytes, and preserved cardiac function. Furthermore, the implantation of adult cardio-ptosis of host cardiomyocytes significantly and enhanced cardiac function. The survival of donor adult cardiomyo-myocytes in combination with bone marrow cells increased the survival of donor adult cardiomyocytes sig-cytes was also increased dramatically by the implantation in combination with bone marrow cells. Fur-nificantly, and induced the myogenic differentiation of donor bone marrow stem cells. These findings indicate thermore, the implantation of adult cardiomyocytes in combination with bone marrow cells increased the myo-that the implantation of adult cardiomyocytes in combination with bone marrow cells is a feasible method for sin-positive bone marrow cells significantly, although the survival of the bone marrow cells was not increased. myocardial repair. These findings suggest that the implantation of adult 
